Drug Interaction Study With a Potential Alzheimer's Disease Compound

Completed · Phase 1

Conditions studied: Alzheimer Disease

In brief

The purpose of this study is to determine whether BMS-708163 will effect the pharmacokinetics of the commonly prescribed medicines midazolam, warfarin, caffeine,omeprazole and dextromethorphan

Key facts

Study ID

NCT00726726

Run by

Bristol-Myers Squibb

People needed

22

Starts

2008-08-01

Expected to finish

2008-10-01

Last updated by the study team

2008-11-05

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy male subjects
• 18-45 yrs old inclusive

You may not qualify if…

• Women

Where it is running

• Bristol-Myers Squibb Clinical Pharmacology Unit — Hamilton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.